Shaheen Alanee
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy (NCT03345134) | Shaheen Alanee | 2017-11-30 |
Track Shaheen Alanee automatically
Every clearance here is in the API, with alerts when new ones post.